A novel chemical compound, NK026680, targets dendritic cells to prolong recipient survival after rat liver grafting

Transplantation

Volumn 84, Issue 3, 2007, Pages 407-414

  Hara, Yoshiaki ^a,b   Funeshima Fuji, Naoko ^a   Fujino, Masayuki ^a,c   Tokunaka, Kazuhiro ^d   Abe, Fuminori ^d   Sato, Yoshinobu ^b   Hatakeyama, Katsuyoshi ^b   Takahara, Shiro ^e   Ezaki, Taichi ^f   Kimura, Hiromitsu ^a   Li, Xiao Kang ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d Central Nippon Expressway Co Ltd   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Allograft; Chemical compound; Dendritic cell; Mixed lymphocyte reaction; Orthotopic liver transplantation

Indexed keywords

ALLOANTIGEN; CD161 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; MESSENGER RNA; NK 026680; TACROLIMUS; TRIAZOLOPYRIDAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; DONOR SELECTION; DOWN REGULATION; DRUG EFFECT; GRAFT SURVIVAL; IMMUNE RESPONSE; IN VITRO STUDY; INHIBITION KINETICS; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; RAT; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD86; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CONCANAVALIN A; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; LIVER TRANSPLANTATION; MALE; MITOGENS; PYRIMIDINES; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TRIAZOLES;

EID: 34547898396     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000270324.28126.93     Document Type: Article

References (30)

1. Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25+CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198: 235.
2. Saiga K, Toyoda E, Tokunaka K, et al. NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice. Bone Marrow Transplant 2006; 37: 317.
3. Saiga K, Tokunaka K, Ichimura E, et al. NK026680, a novel suppressant of dendritic cell function, prevents the development of rapidly progressive glomerulonephritis and perinuclear antineutrophil cytoplasmic antibody in SCG/Kj mice. Arthritis Rheum 2006; 54: 3707.
4. Yan H, Miyagi T, Satoh E, et al. Phenotype and function of GM-CSF independent dendritic cells generated by long-term propagation of rat bone marrow cells. Cell Immunol 2004; 229: 117.
5. Funeshima N, Fujino M, Kitazawa Y, et al. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase. J Gene Med 2005; 7: 565.
6. Lu FZ, Fujino M, Kitazawa Y, et al. Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood. J Lab Clin Med 2005; 146: 271.
7. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28: 47.
8. Adachi K, Fujino M, Kitazawa Y, et al. Genetic heterogeneity and efficiency of two different methods of adenovirus-mediated gene transfer in a rat liver transplantation model. Surg Today 2006; 36: 367.
9. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245.
10. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767.
11. Rastellini C, Lu L, Ricordi C, et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
12. Fu F, Li Y, Qian S, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
13. Peche H, Trinite B, Martinet B, Cuturi MC. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 2005; 5: 255.
14. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
15. Woltman AM, de Fijter JW, Kamerling SW, et al. Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 2001; 98: 174.
16. Lu L, Thomson AW. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002; 73 (1 Suppl): S19.
17. Koski GK, Lyakh LA, Cohen PA, Rice NR. CD14+ monocytes as dendritic cell precursors: Diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB. Crit Rev Immunol 2001; 21: 179.
18. Neumann M, Fries H, Scheicher C, et al. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000; 95: 277.
19. Sato K, Yamashita N, Baba M, Matsuyama T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003; 18: 367.
20. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996; 80: 225.
21. Zhou X, Schmidtke P, Zepp F, Meyer CU. Boosting interleukin-10 production: therapeutic effects and mechanisms. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 465.
22. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994; 6: 458.
23. Trinchieri G. The two faces of interleukin 12: A pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells. Ciba Found Symp 1995; 195: 203.
24. Lee JI, Ganster RW, Geller DA, et al. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: Association with reduced nuclear translocation of nuclear factor kappa B. Transplantation 1999; 68: 1255.
25. Woltman AM, de Fijter JW, Kamerling SW, et al. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000; 30: 1807.
26. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999; 162: 6473.
27. Manome H, Aiba S, Singh S, Yoshino Y, Tagami H. Dexamethasone and cyclosporin A affect the maturation of monocyte-derived dendritic cells differently. Int Arch Allergy Immunol 2000; 122: 76.
28. Rea D, van Kooten C, van Meijgaarden KE, et al. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 2000; 95: 3162.
29. Bennett WM, DeMattos A, Meyer MM, et al. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089.
30. Abramowicz D, Wissing KM, Broeders N. Nephrotoxicity of calcineurin inhibitors: new therapeutic approaches. Transplant Proc 2000; 32(1A Suppl): 3S.